Hellenic Dynamics has entered into an agreement for conducting research on cannabis in Greece.

Hellenic Dynamics Plc (LSE: HELD) has inked a five-year deal with ELGO-DIMITRA, an Institute of Plant Breeding and Genetic Resources located in Greece, to collaborate on research and projects.

ELGO-DIMITRA is a public sector entity under the Greek Ministry of Agriculture, Development and Food that focuses on agricultural research, quality certification and agricultural products.

The collaboration agreement involves joint research, cultivation, evaluation and utilization of specific strains of medical cannabis genetics to produce new varieties and species of cannabis that offer improved quality, yield and adaptability.

Hellenic anticipates that the research will aid its efforts to register its cannabis products in Greece, potentially resulting in Intellectual Property protection on certain genetics, which could be enforced throughout Europe.

Davinder Rai, CEO of Hellenic Dynamics, commented:   “This MoU with ELGO-DIMITRA is very exciting as it means the Company could gain IP protection on its strains of THC medical cannabis flowers which could be incredibly valuable , especially if efficacy can be shown in patients against specific pain indicators.”

Professor Serkos Haroutounian, President of the board ELGO-DIMITRA , commented:  

“The experienced and specialized staff of ELGO  DIMITRA’s Research Institute provide knowledge and contributes to the development of the agricultural production of Greece. With the M oU signed, the Institute of Plant Breeding and Genetic Resources, which deals with the experimental cultivation of medicinal cannabis, intends to proceed, in cooperation with Hellenic Dynamics, with the creation of new varieties of medicinal cannabis, the control of stabilisation of genetic material and selection of mother plants, the study of innovative systems cultivation in greenhouses and closed chambers as well as in the submission of new research proposals .”

Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

Weekly Newsletter

Sign up to receive exclusive stock market content in your inbox, once a week.

We don’t spam! Read our privacy policy for more info.